FIVE PRIME THERAPEUTICS, INC. Insider Trading for October 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in FIVE PRIME THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in FIVE PRIME THERAPEUTICS, INC. for October 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 31 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.85 | 504 | 1,940 | 348,827 | 348.3 K to 348.8 K (+0.14 %) |
| Oct 31 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.85 | 2,913 | 11,214 | 1,996,638 | 2 M to 2 M (+0.15 %) |
| Oct 31 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.85 | 3,416 | 13,150 | 2,461,782 | 2.5 M to 2.5 M (+0.14 %) |
| Oct 31 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.89 | 1,456 | 5,667 | 348,323 | 346.9 K to 348.3 K (+0.42 %) |
| Oct 31 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.89 | 8,236 | 32,055 | 1,993,725 | 2 M to 2 M (+0.41 %) |
| Oct 31 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.89 | 10,389 | 40,435 | 2,458,366 | 2.4 M to 2.5 M (+0.42 %) |
| Oct 31 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.90 | 240 | 935 | 346,867 | 346.6 K to 346.9 K (+0.07 %) |
| Oct 31 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.90 | 1,133 | 4,415 | 1,985,489 | 2 M to 2 M (+0.06 %) |
| Oct 31 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.90 | 1,027 | 4,002 | 2,447,977 | 2.4 M to 2.4 M (+0.04 %) |
| Oct 25 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.75 | 2,155 | 8,075 | 346,627 | 344.5 K to 346.6 K (+0.63 %) |
| Oct 25 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.75 | 12,899 | 48,336 | 1,984,356 | 2 M to 2 M (+0.65 %) |
| Oct 25 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.75 | 15,728 | 58,938 | 2,446,950 | 2.4 M to 2.4 M (+0.65 %) |
| Oct 25 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.74 | 1,629 | 6,100 | 344,472 | 342.8 K to 344.5 K (+0.48 %) |
| Oct 25 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.74 | 57,723 | 216,155 | 1,971,457 | 1.9 M to 2 M (+3.02 %) |
| Oct 25 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.74 | 76,036 | 284,732 | 2,431,222 | 2.4 M to 2.4 M (+3.23 %) |
| Oct 25 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.75 | 3,200 | 11,986 | 2,355,186 | 2.4 M to 2.4 M (+0.14 %) |
| Oct 21 2019 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Interim CEO | Option Exercise | A | 3.99 | 46,939 | 187,287 | 46,939 | |
| Oct 08 2019 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Interim CEO | Option Exercise | A | 3.79 | 34,451 | 130,569 | 34,451 | |
| Oct 08 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.68 | 4,689 | 17,270 | 342,843 | 338.2 K to 342.8 K (+1.39 %) |
| Oct 08 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.68 | 24,716 | 91,029 | 1,913,734 | 1.9 M to 1.9 M (+1.31 %) |
| Oct 08 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.68 | 31,007 | 114,199 | 2,351,986 | 2.3 M to 2.4 M (+1.34 %) |
| Oct 08 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.75 | 24,425 | 91,594 | 338,154 | 313.7 K to 338.2 K (+7.79 %) |
| Oct 08 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.75 | 14,242 | 53,382 | 313,729 | 299.5 K to 313.7 K (+4.76 %) |
| Oct 08 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.75 | 138,609 | 519,784 | 1,889,018 | 1.8 M to 1.9 M (+7.92 %) |
| Oct 08 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.75 | 80,821 | 302,933 | 1,750,409 | 1.7 M to 1.8 M (+4.84 %) |
| Oct 08 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.75 | 168,640 | 632,400 | 2,320,979 | 2.2 M to 2.3 M (+7.84 %) |
| Oct 08 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.75 | 98,333 | 368,572 | 2,152,339 | 2.1 M to 2.2 M (+4.79 %) |
| Oct 08 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.74 | 991 | 3,704 | 299,487 | 298.5 K to 299.5 K (+0.33 %) |
| Oct 08 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.74 | 7,314 | 27,336 | 1,669,588 | 1.7 M to 1.7 M (+0.44 %) |
| Oct 08 2019 | FPRX | FIVE PRIME THERAPE ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.74 | 7,695 | 28,760 | 2,054,006 | 2 M to 2.1 M (+0.38 %) |